Strategic Partnering Opportunities

Vironika, LLC, is a pioneering developer of small molecule inhibitors for the treatment of cancer caused by tumor viruses. Vironika seeks partners to accelerate product development and commercialization and to facilitate the sales and distribution of future products. Vironika’s technology is expected to have applications in the treatment of tumors caused by Epstein Barr Virus or other cancer-causing viruses.